Anti-GPNMB Antibody (Glembatumumab vedotin)
Catalog No.
F1091
Anti-GPNMB Antibody (Glembatumumab vedotin)
Featured Products
Glembatumumab vedotin (CDX-011) is an ADC (Antibody-Drug Conjugates (ADCs)) consisting of a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulin-binding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.56 kDa
Dry ice
1182215-65-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
glembatumumab, CR011, CR011-vcMMAE
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q14956
Human
MMAE
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
The drug-to-antibody ratio (DAR) of the Anti-GPNMB Antibody (Glembatumumab vedotin) is 3.6.
GPNMB
Please avoid freeze-thaw cycles.